AQUESTIVE Trademark

Trademark Overview

On Monday, June 15, 2015, a trademark application was filed for AQUESTIVE with the United States Patent and Trademark Office. The USPTO has given the AQUESTIVE trademark a serial number of 86662567. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, May 16, 2025. This trademark is owned by MonoSol Rx, LLC. The AQUESTIVE trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of pharmaceutical drug preparations
aquestive

General Information

Serial Number86662567
Word MarkAQUESTIVE
Filing DateMonday, June 15, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, May 16, 2025
Registration Number5680872
Registration DateTuesday, February 19, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2015

Trademark Statements

Goods and ServicesDrug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of pharmaceutical drug preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 18, 2015
Primary Code005
First Use Anywhere DateWednesday, November 28, 2018
First Use In Commerce DateWednesday, November 28, 2018

Trademark Owner History

Party NameAQUESTIVE THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
Party NameAQUESTIVE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWARREN, NJ 07059
Party NameMonoSol Rx, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059
Party NameMonoSol Rx, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059

Trademark Events

Event DateEvent Description
Thursday, September 24, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 18, 2015NEW APPLICATION ENTERED
Thursday, June 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 23, 2015ASSIGNED TO EXAMINER
Thursday, December 15, 2016SOU EXTENSION 2 FILED
Wednesday, October 14, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 3, 2015PUBLISHED FOR OPPOSITION
Tuesday, November 3, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 11, 2016SOU TEAS EXTENSION RECEIVED
Monday, April 11, 2016SOU EXTENSION 1 FILED
Monday, April 11, 2016SOU EXTENSION 1 GRANTED
Wednesday, April 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 15, 2016SOU EXTENSION 2 GRANTED
Saturday, December 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, June 14, 2017SOU EXTENSION 3 FILED
Wednesday, June 14, 2017SOU EXTENSION 3 GRANTED
Friday, June 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2017SOU EXTENSION 4 FILED
Wednesday, December 13, 2017SOU EXTENSION 4 GRANTED
Friday, December 14, 2018USE AMENDMENT FILED
Tuesday, December 18, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 15, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 31, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 13, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, June 13, 2018SOU EXTENSION 5 FILED
Friday, June 15, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 15, 2018SOU EXTENSION 5 GRANTED
Saturday, June 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 14, 2018TEAS STATEMENT OF USE RECEIVED
Friday, July 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 16, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 19, 2019REGISTERED-PRINCIPAL REGISTER
Monday, February 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, January 27, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, May 16, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 16, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 16, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

aquestive film drug delivery facilitate pharmaceutical preparations transmucosal soluble agents form